Save time and get answers to complex questions with AI chat
Pramlintide approval date?How many years does kadcyla's market exclusivity last?Defense strategy against generic in niche market?What's the recommended schedule for lurbinectedin side effect checks?Patent term adjustment semaglutida?
See the DrugPatentWatch profile for Methotrexate
Methotrexate inhibits dihydrofolate reductase (DHFR), the enzyme that regenerates tetrahydrofolate needed for DNA synthesis in rapidly dividing cells. This blocks folate-dependent production of nucleotides. [1]
By inhibiting DHFR, methotrexate reduces tetrahydrofolate availability, which in turn impairs the formation of DNA building blocks (purines and thymidylate). Cells that rely on active DNA replication are most affected. [1]
Methotrexate’s best-known mechanism is DHFR inhibition. It can also increase intracellular levels of other folate forms that further disrupt folate-dependent metabolic pathways, reinforcing the anti-proliferative effect. [1]
Because the drug interferes with folate-dependent DNA synthesis, it helps treat conditions where slowing cell proliferation matters, including some cancers and inflammatory autoimmune diseases (like rheumatoid arthritis and psoriasis). [1] Source 1. Drugs.com – Methotrexate: Uses, Dosage, Side Effects & Mechanism of Action
Other Questions About Methotrexate :